Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

HER 2: Interpretation of ICH and FISH Assays - Molecular Pathology Education Module 3

Share :
Published: 17 Feb 2010
Views: 7052
Rating:
Save
Professor Giuseppe Viale - European Institute of Oncology
Module 3: Interpretation of results of ICH and FISH Assays
Professor Viale, from the European Institute of Oncology, interprets the results of ICH and FISH assays.

Module 3 of 4

Related Videos

EBCC 2024: Addressing inequalities across Europe in access to innovation for...
Dr Fiorita Poulakaki (Athens Medical Centre Hospital, Athens, Greece) and Dr...
EBCC 2024: Addressing inequalities across Europe in access to innovation for patients with metastatic breast cancer ( Dr Fiorita Poulakaki (Athens Medical Centre Hospital, Athens, Greece) and Dr Michail Ignatiadis (Institut Jules Bordet, Brussels, Belgium) )
25 Apr 2024
Comment: EBCC 2024 highlights
Dr Fiorita Poulakaki (Athens Medical Centre Hospital, Athens, Greece) andDr...
Comment: EBCC 2024 highlights ( Dr Fiorita Poulakaki (Athens Medical Centre Hospital, Athens, Greece) andDr Michail Ignatiadis (Institut Jules Bordet, Brussels, Belgium) )
25 Apr 2024
Saruparib shows encouraging efficacy and safety in mutant advanced solid tumours
Dr Timothy Yap - The University of Texas MD Anderson Cancer Center, Housten, USA
Saruparib shows encouraging efficacy and safety in mutant advanced solid tumours ( Dr Timothy Yap - The University of Texas MD Anderson Cancer Center, Housten, USA )
24 Apr 2024
Avelumab combined with regorafenib shows improved outcome in solid tumours with...
Prof Antoine Italiano - Institute Bergonié, Bordeaux, France
Avelumab combined with regorafenib shows improved outcome in solid tumours with tertiary lymphoid structures ( Prof Antoine Italiano - Institute Bergonié, Bordeaux, France )
24 Apr 2024
Pembrolizumab improves breast cancer outcomes regardless of age or menopausal...
Dr Javier Cortes - International Breast Cancer Center, Barcelona, Spain
Pembrolizumab improves breast cancer outcomes regardless of age or menopausal status ( Dr Javier Cortes - International Breast Cancer Center, Barcelona, Spain )
26 Mar 2024
Using AI to identify patients at increased risk of side effects from radiation...
Dr Tim Rattay - University of Leicester Cancer Research Centre, Leicester, UK
Using AI to identify patients at increased risk of side effects from radiation treatment for breast cancer ( Dr Tim Rattay - University of Leicester Cancer Research Centre, Leicester, UK )
25 Mar 2024
ESMO 2023: Highlights and analysis
Dr Bishal Gyawali - Queen's University, Kingston, Canada
ESMO 2023: Highlights and analysis ( Dr Bishal Gyawali - Queen's University, Kingston, Canada )
8 Nov 2023
OncoAlert round up July 28th to August 3rd, 2023
Dr Gil Morgan - Executive Director, OncoAlert
OncoAlert round up July 28th to August 3rd, 2023 ( Dr Gil Morgan - Executive Director, OncoAlert )
4 Aug 2023
Choosing Wisely in implementing prevention, screening and early detection...
Dr Gad Murenzi - Rwanda Military Hospital, Kigali, Rwanda
Choosing Wisely in implementing prevention, screening and early detection programs in Africa ( Dr Gad Murenzi - Rwanda Military Hospital, Kigali, Rwanda )
3 Feb 2023

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation